Track topics on Twitter Track topics that are important to you
Xcellerex is revolutionizing the way biomolecules are developed, manufactured and commercialized. The companyâs unique single-use component technology platform transforms biomanufacturing economics, enabling the development of biotherapeutics and vaccines, and dramatically improving the ability of Xcellerex and its partners to deploy manufacturing capacity. Xcellerex leverages its technology and services platform by: 1) commercializing its FlexFactoriesÂ® (complete, turnkey, modular production trains) and XDR (unique, single-use component bioreactor systems); 2) building a portfolio of proprietary biotherapeutics and vaccines through creative alliances and in licensing; and 3) creatively structuring transactions around FlexFactories, XDRs and its pipeline. Based in Marlborough, Massachusetts, Xcellerex is backed by an experienced management team and top-tier venture investors including Kleiner Perkins Caufield & Byers, VantagePoint Venture Partners and SCG Capital. For more information, please visit the companyâs website at http://www.xcellerex.com
170 Locke Drive
United States of America
Phone: (508) 480-9235
Xcellerex is revolutionizing the way biomolecules are developed, manufactured and commercialized. The companyâs unique single-use component technology platform transforms bio...
We have published hundreds of Xcellerex, Inc. news stories on BioPortfolio along with dozens of Xcellerex, Inc. Clinical Trials and PubMed Articles about Xcellerex, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Xcellerex, Inc. Companies in our database. You can also find out about relevant Xcellerex, Inc. Drugs and Medications on this site too.
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...